172 related articles for article (PubMed ID: 18268491)
1. Cortactin expression predicts poor survival in laryngeal carcinoma.
Gibcus JH; Mastik MF; Menkema L; de Bock GH; Kluin PM; Schuuring E; van der Wal JE
Br J Cancer; 2008 Mar; 98(5):950-5. PubMed ID: 18268491
[TBL] [Abstract][Full Text] [Related]
2. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
Gibcus JH; Menkema L; Mastik MF; Hermsen MA; de Bock GH; van Velthuysen ML; Takes RP; Kok K; Alvarez Marcos CA; van der Laan BF; van den Brekel MW; Langendijk JA; Kluin PM; van der Wal JE; Schuuring E
Clin Cancer Res; 2007 Nov; 13(21):6257-66. PubMed ID: 17975136
[TBL] [Abstract][Full Text] [Related]
3. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
4. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
[TBL] [Abstract][Full Text] [Related]
5. FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy.
Schrijvers ML; Pattje WJ; Slagter-Menkema L; Mastik MF; Gibcus JH; Langendijk JA; van der Wal JE; van der Laan BF; Schuuring E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1220-6. PubMed ID: 22208968
[TBL] [Abstract][Full Text] [Related]
6. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
8. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ
Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309
[TBL] [Abstract][Full Text] [Related]
9. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
11. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
12. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
Bringuier PP; Tamimi Y; Schuuring E; Schalken J
Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.
Rasamny JJ; Allak A; Krook KA; Jo VY; Policarpio-Nicolas ML; Sumner HM; Moskaluk CA; Frierson HF; Jameson MJ
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):923-31. PubMed ID: 22323434
[TBL] [Abstract][Full Text] [Related]
16. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.
Gibcus JH; Kok K; Menkema L; Hermsen MA; Mastik M; Kluin PM; van der Wal JE; Schuuring E
Hum Genet; 2007 Apr; 121(2):187-201. PubMed ID: 17171571
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage.
Fracchiolla NS; Pruneri G; Pignataro L; Carboni N; Capaccio P; Boletini A; Buffa R; Neri A
Cancer; 1997 Mar; 79(6):1114-21. PubMed ID: 9070488
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
[TBL] [Abstract][Full Text] [Related]
20. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
